Business
The pharmaceutical industry has long grappled with lengthy timelines and low success rates for new drugs and treatments.
Hi, what are you looking for?
The pharmaceutical industry has long grappled with lengthy timelines and low success rates for new drugs and treatments.
The report is critical of five nations in particular: Japan, Italy, Germany, France, and the U.K. In each of these countries, price controls are...
A new collaboration between academia and industry in the clinical trials space is set to help to bring drugs to market faster.
These applications impact everything from R&D, supply chain, to manufacturing and finance. That vendor should also have a strong track record .
At a time when hospitals and patients are strained due to increasing COVID numbers, threat actors will continue to attack.